Colleges
-
‘A one-and-done treatment’: UChicago Medicine among the first in the U.S. to use TIL therapy for advanced skin cancer
For 15 years, Alla Pinzour traveled the country seeking treatments for her advanced melanoma. Some would bring temporary remission, but her skin cancer always returned. “Surgeries, chemo, radiation — you name it, I had it done,” she said. “Nothing seemed to work.” By early 2024, Pinzour’s skin cancer had spread to other places in her body, including her lungs and…
Read More » -
WCM-Q to host second alumni-led primary care conference
Weill Cornell Medicine-Qatar (WCM-Q) will host its second annual Updates in Primary Care conference on November 29 and 30 in Doha, Qatar. The conference, titled ‘Updates in Primary Care: Specialist-Led Case-Based Discussions Highlighting the Latest Evidence and Best Clinical Practice – 2024,’ reflects WCM-Q’s commitment to delivering cutting-edge, practical education. Organized entirely by graduates of the college, the two-day conference…
Read More » -
Theranostics treatments for cancer underway at UCLA Health
UCLA Health’s new leading-edge theranostics center, using targeted radioactive drugs to treat advanced cancer, is now open. Offering state-of-the-art facilities and expertise, the 3,000-square-foot Outpatient Theranostics Center in Westwood, part of the UCLA Health Jonsson Comprehensive Cancer Center, specializes in radiopharmaceutical therapy. It is one of the largest of its kind in the United States, according to Jeremie Calais, MD,…
Read More » -
Ghaith Abu-Zeinah, M.D.
Assistant Professor of Medicine, Division of Hematology and Oncology, Weill Cornell Medicine, New York Assistant Attending Physician, NewYork-Presbyterian Hospital Visiting Faculty Member, Weill Cornell Medicine-Qatar “The general symptoms of MPNs include fatigue, headaches, weight loss, and night sweats.” Dr. Ghaith Abu-Zeinah is an Assistant Professor of Medicine in the Division of Hematology and Oncology at Weill Cornell Medicine in New…
Read More » -
UChicago Medicine among the first in the country to offer newly approved sickle cell gene therapies
The University of Chicago Medicine Comer Children’s Hospital will be among the first in the country to offer gene therapy for sickle cell disease in patients 12 years and older, after federal regulators approved two new treatments on December 8, 2023. Thousands of patients with sickle cell disease experience complications including anemia, vaso-occlusive crises (VOCs), acute chest syndrome (ACS) and…
Read More » -
WCM-Q students probe the effects of weight loss drugs on diabetes, obesity and cancer
Students at Weill Cornell Medicine-Qatar (WCM-Q) have made a significant contribution to the field by publishing a study that delves into the effects of Ozempic-type drugs on the interconnected health challenges of obesity, diabetes, and cancer. Ozempic, the brand name of a drug called semaglutide, belongs to a class of medications called glucagon-like peptide-1 receptor (GLP-1R) agonists. These medications have…
Read More » -
An Open Health Day for Mount Lebanon Hospital University Medical Center (MLHUMC) in collaboration with Balamand University
An Open Health Day for Mount Lebanon Hospital University Medical Center (MLHUMC) in collaboration with Balamand University A unique initiative that combines treatment to research in presence of top-notch specialists Small signs might be an alarm to overlaying more serious health issues. In this perspective, Mount Lebanon Hospital University Medical Center (MLHUMC) organized together with Balamand University in Dekwaneh, an…
Read More » -
Robotic Mitral Valve Surgery Helps Patient Get Back to Active Lifestyle Quickly
Dan Moceri knew for years that he had a mitral valve prolapse — a heart valve disease that causes blood to leak backward into the left upper chamber of the heart. But when his wife was diagnosed with an aggressive brain tumor, he put his own health issues on the back burner for five years to care for her. After…
Read More » -
Mohammad Yousef, Ph.D.
“Physics is a fundamental science that underpins much of modern medicine.” Dr. Mohammad Yousef is a Professor of Physics at Weill Cornell Medicine-Qatar (WCM-Q). He previously served as an Associate Professor of Physics at Southern Illinois University Edwardsville. Dr. Yousef is an experienced educator who has taught physics courses tailored to the needs of health science, as well as pre-professional…
Read More » -
‘OR of the future’ houses new tech to view the brain like never before
You may have heard stories of patients remaining awake and being asked to converse or even sing while receiving brain surgery. Although it may seem strange, this practice has long served as an effective way for brain surgeons to assess brain function mid-surgery to help ensure they don’t damage important tissue or neurons. But leading neurosurgeons now have tools that…
Read More »